Wave Life Sciences Ltd. Ordinary Shares

$6.075
USD
Last updated on --.
24h volume159.90K
24h highest6.0790 USD
24h lowest5.9150 USD
24h Price movement+2.45%

WVE recent prices

24 Hours
+2.45%+$0.145
30 days
-6.90%-$0.44
60 days
+4.21%+$0.24
90 days
-17.27%-$1.240

Key data

Previous close5.9300 USD
Market cap1.13B USD
Volume159.90K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.93000 USD
Net income (FY)-183.59M USD
Revenue (FY)71.80M USD
Last report dateApr 28, 2026

About Wave Life Sciences Ltd. Ordinary Shares

PHARMACEUTICAL PREPARATIONS
HeadquartersSINGAPORE
Employees (FY)317.00
Revenue per employee (FY)226.49K USD
Net income per employee (FY)-579.14K USD
Listed onNasdaq
Official website

WVE conversion tables

WVEWVE
USDUSD
0.5 WVE3.037 USD
1 WVE6.075 USD
5 WVE30.37 USD
10 WVE60.75 USD
USDUSD
WVEWVE
0.5 USD0.082305 WVE
1 USD0.16461 WVE
5 USD0.82305 WVE
10 USD1.646 WVE

FAQ

WVE is trading at $6.075, +2.45% over the last 24 hours. Track live moves on the price chart at the top of this page.
The WVE stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. WVE is currently trading at $6.075, +2.45% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on WVE price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. WVE's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from WVE; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against WVE's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Wave Life Sciences Ltd. Ordinary Shares's market cap is currently 1.13B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume159.90K
24h highest6.0790 USD
24h lowest5.9150 USD
24h Price movement+2.45%
WVEWVE
USDUSD
Start trade with WVE Perpetual